Mesoblast Limited (MEOBF)
Mesoblast Statistics
Share Statistics
Mesoblast has 1.28B shares outstanding. The number of shares has increased by 11.19% in one year.
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | 11.19% |
| Shares Change (QoQ) | 10.7% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 37.46M, so 2.95% of the outstanding shares have been sold short.
| Short Interest | 37.46M |
| Short % of Shares Out | 2.95% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 999.99 |
Valuation Ratios
The PE ratio is -7.4 and the forward PE ratio is null. Mesoblast's PEG ratio is 0.39.
| PE Ratio | -7.4 |
| Forward PE | n/a |
| PS Ratio | 110.34 |
| Forward PS | n/a |
| PB Ratio | 1.36 |
| P/FCF Ratio | -13.35 |
| PEG Ratio | 0.39 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mesoblast.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.18 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | -1.89 |
| Debt / FCF | -2.44 |
| Interest Coverage | -2.81 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $80,849.32 |
| Profits Per Employee | $-1,204,876.71 |
| Employee Count | 73 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 40.89 |
Taxes
| Income Tax | -191K |
| Effective Tax Rate | 0.22% |
Stock Price Statistics
The stock price has increased by 89.47% in the last 52 weeks. The beta is 2.03, so Mesoblast's price volatility has been higher than the market average.
| Beta | 2.03 |
| 52-Week Price Change | 89.47% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 39,462 |
Income Statement
In the last 12 months, Mesoblast had revenue of 5.9M and earned -87.96M in profits. Earnings per share was -0.09.
| Revenue | 5.9M |
| Gross Profit | -10.09M |
| Operating Income | -57.97M |
| Net Income | -87.96M |
| EBITDA | -62.82M |
| EBIT | -67.49M |
| Earnings Per Share (EPS) | -0.09 |
Balance Sheet
The company has 62.56M in cash and 118.92M in debt, giving a net cash position of -56.36M.
| Cash & Cash Equivalents | 62.56M |
| Total Debt | 118.92M |
| Net Cash | -56.36M |
| Retained Earnings | -908.76M |
| Total Assets | 669.15M |
| Working Capital | 13.22M |
Cash Flow
In the last 12 months, operating cash flow was -48.46M and capital expenditures -331K, giving a free cash flow of -48.79M.
| Operating Cash Flow | -48.46M |
| Capital Expenditures | -331K |
| Free Cash Flow | -48.79M |
| FCF Per Share | -0.05 |
Margins
Gross margin is -170.9%, with operating and profit margins of -982.24% and -1490.27%.
| Gross Margin | -170.9% |
| Operating Margin | -982.24% |
| Pretax Margin | -1493.51% |
| Profit Margin | -1490.27% |
| EBITDA Margin | -1064.44% |
| EBIT Margin | -982.24% |
| FCF Margin | -826.65% |
Dividends & Yields
MEOBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for MEOBF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 11, 2023. It was a forward split with a ratio of 527:500.
| Last Split Date | Dec 11, 2023 |
| Split Type | forward |
| Split Ratio | 527:500 |
Scores
| Altman Z-Score | 3.93 |
| Piotroski F-Score | 2 |